Sign-in to Ask A Doctor - 24x7
OR
Sign in with Google
Suggest Treatment For A CLL Patient Treated With Fludarabine Or Rituximab
Question: Which prophylactic treatment are recommended for CLL patent treated with flurdarabine or rituximab? Why?
A. Patients should be given predrisone or dexamethasone to minimize the effects of tumor lysis syndrome.
B. Patients should be given predrisone or dexamethasone to minimize the effect od uremic-hemolytic syndrome.
C. Patients should be hydrated and given allopurinol or rasburicase to minimize the effects of uremic-hemplytic
D. Patients should be hydrated and given allopurinol or rasburicase to minimize the effects of tumor lysis syndrome
A. Patients should be given predrisone or dexamethasone to minimize the effects of tumor lysis syndrome.
B. Patients should be given predrisone or dexamethasone to minimize the effect od uremic-hemolytic syndrome.
C. Patients should be hydrated and given allopurinol or rasburicase to minimize the effects of uremic-hemplytic
D. Patients should be hydrated and given allopurinol or rasburicase to minimize the effects of tumor lysis syndrome
Brief Answer:
the answer should be D
Detailed Answer:
These newer therapies cause high rate of cell kill which can cause lot of tumor lysis.
Hence hydration and allopurinol are given prophylactically
the answer should be D
Detailed Answer:
These newer therapies cause high rate of cell kill which can cause lot of tumor lysis.
Hence hydration and allopurinol are given prophylactically
Note: For further queries related to kidney problems Click here.
Above answer was peer-reviewed by :
Dr. Chakravarthy Mazumdar
Answered by
Get personalised answers from verified doctor in minutes across 80+ specialties
